A cancer medicine comes from China

A cancer medicine comes from China "Petrovaks" agreed about deliveries onkopreparatov After restriction of presence to Russian Federation the western pharmaceutical companies the Russian players are compelled to look for partners to Asia. "Petrovaks", to LLC "KHK INTERROS" Vladimir Potanin, agreed with the Chinese Jiangsu Hengrui about deliveries and the subsequent localization of several onkopreparatov, including kamrelizumab, relating besides to a class, as "Kitruda" from Merck Sharp & Dohme. But, despite active development the market, the Chinese companies cannot compete on innovation yet and to quality with...